Histogen Inc.
NASDAQ Capital MarketTotal Valuation
Histogen Inc. carries a market capitalization of 85,435.00, placing it among publicly traded companies globally. Its enterprise value stands at -3.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 85,435.00 |
| Enterprise Value | -3.43M |
Share Statistics
Histogen Inc. currently has 4.27M shares outstanding.
| Shares Outstanding | 4.27M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 114.66, and the price-to-book ratio stands at -0.02.
| PE Ratio | N/A |
| PS Ratio | 114.66 |
| PB Ratio | -0.02 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | -0.22 |
| P/OCF Ratio | -0.22 |
Financial Position
Histogen Inc. maintains a current ratio of 4.05, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.05 |
| Quick Ratio | 3.39 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -88.39 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Histogen Inc.'s stock has declined approximately -93.73041% over the past 52 weeks. The 50-day moving average sits at - -, while the 200-day moving average is - -.
| Beta (5Y) | N/A |
| 52-Week Price Change | -93.73041% |
| 50-Day Moving Average | - - |
| 200-Day Moving Average | - - |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Histogen Inc. generated 19,000.00 in revenue and converted that into -12.38M in net income, yielding earnings per share of -2.90. EBITDA reached -11.92M, while operating income came in at -12.05M.
| Revenue | 19,000.00 |
| Gross Profit | 4,000.00 |
| Operating Income | -12.05M |
| Pretax Income | -12.38M |
| Net Income | -12.38M |
| EBITDA | -11.92M |
| EBIT | -12.05M |
| Earnings Per Share (EPS) | -2.90 |
Balance Sheet
Total book value stands at -97.68M, with working capital of 4.11M providing operational flexibility.
| Cash & Cash Equivalents | 4.57M |
| Total Debt | N/A |
| Net Debt | -4.57M |
| Equity (Book Value) | -97.68M |
| Book Value Per Share | -22.87 |
| Working Capital | 4.11M |
Cash Flow
Histogen Inc. produced -10.07M in operating cash flow over the past twelve months. After subtracting -1,000.00 in capital expenditures, free cash flow totaled -10.07M - equivalent to -2.36 per share.
| Operating Cash Flow | -10.07M |
| Capital Expenditures | -1,000.00 |
| Free Cash Flow | -10.07M |
| FCF Per Share | -2.36 |
Margins
Histogen Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -63,447.37 and net profit margin of -65,142.11 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -63,447.37 |
| Pretax Margin | -65,178.95 |
| Profit Margin | -65,142.11 |
| EBITDA Margin | -62,721.05 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.78 |
| FCF Yield | -462.36 |
Stock Splits
Histogen Inc.'s most recent stock split took place on June 3, 2022 with a 20:1 split ratio.
| Last Split Date | 6/3/2022 |
| Split Ratio | 20:1 |
Scores
Histogen Inc. posts an Altman Z-Score of -28.57, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -28.57 |